These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11980)

  • 1. A method for the measurement of L-phenylalanine mustard in the mouse and dog by high-pressure liquid chromatography.
    Furner RL; Mellett LB; Brown RK; Duncan G
    Drug Metab Dispos; 1976; 4(6):577-83. PubMed ID: 11980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the absorption, distribution, and elimination of melphalan in the dog.
    Furner RL; Brown RK; Duncan G
    Cancer Treat Rep; 1977 Dec; 61(9):1637-46. PubMed ID: 597816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustard.
    Bolton MG; Colvin OM; Hilton J
    Cancer Res; 1991 May; 51(9):2410-5. PubMed ID: 2015603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis products.
    Flora KP; Smith SL; Cradock JC
    J Chromatogr; 1979 Sep; 177(1):91-7. PubMed ID: 536450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 requirement for the in vitro generation of antitumor cytotoxicity by thymocytes from melphalan-cured MOPC-315 tumor bearers.
    Mokyr MB; Bartik MM; Ahn MC
    Cancer Res; 1989 Feb; 49(4):870-6. PubMed ID: 2783557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma.
    Osterheld HK; Musch E; von Unruh GE; Loos U; Rauschecker H; Mühlenbruch BJ
    Cancer Chemother Pharmacol; 1988; 21(2):156-62. PubMed ID: 3349564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
    Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice.
    Lu W; He LC; Zeng XM
    J Pharm Biomed Anal; 2008 Jan; 46(1):170-6. PubMed ID: 17889477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.
    Wang H; Li M; Rhie JK; Hockenbery DM; Covey JM; Zhang R; Hill DL
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.
    Tesoro A; Leeder JS; Bentur Y; Klein J; Freedman M; Koren G
    Ther Drug Monit; 1989; 11(4):463-70. PubMed ID: 2741196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and elimination of melphalan in rats and monkeys and distribution in tumors of mice bearing L1210 or P388 leukemias sensitive and resistant to this agent.
    Brown RK; Duncan G; Hill DL
    Cancer Treat Rep; 1980; 64(4-5):643-8. PubMed ID: 6775804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and excretion of (3H)vincristine in the rat and the dog.
    Castle MC; Margileth DA; Oliverio VT
    Cancer Res; 1976 Oct; 36(10):3684-9. PubMed ID: 953993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies on the efficacy of PAM against sumithion poisoning].
    Sekita K
    Nihon Hoigaku Zasshi; 1992 Feb; 46(1):14-31. PubMed ID: 1597930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.